Literature DB >> 8408114

Adsorption/desorption of human serum albumin at the surface of poly(lactic acid) nanoparticles prepared by a solvent evaporation process.

T Verrecchia1, P Huve, D Bazile, M Veillard, G Spenlehauer, P Couvreur.   

Abstract

Biocompatible and biodegradable nanoparticles of poly(lactic acid) (100% L-lactic units = PLA) were prepared by an emulsion, microfluidization, and solvent evaporation method using human serum albumin (HSA) as a surface agent. A radiolabeling technique was employed to quantify the serum albumin bound to the nanoparticles and to measure its desorption kinetics in various media at 22 degrees C and 37 degrees C (phosphate buffer pH 7.4, serum albumin 40 g/L in phosphate buffer pH 7.4 and fetal calf serum). The amount of serum albumin bound to the nanoparticles was found to be a linear function of 1/D (where D is the nanoparticle mean diameter) and was related to the total developed area of the nanoparticles. The adsorption/desorption behavior of serum albumin at the surface of the nanoparticles suggested a multilayer adsorption model. Moreover, a part of the serum albumin molecules was irreversibly bound regardless of the incubation conditions. Consequently, the classical Langmuirian theories of equilibria could not be applied.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8408114     DOI: 10.1002/jbm.820270807

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  11 in total

1.  Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice.

Authors:  T Jung; W Kamm; A Breitenbach; K D Hungerer; E Hundt; T Kissel
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

2.  An assessment of the effects of shell cross-linked nanoparticle size, core composition, and surface PEGylation on in vivo biodistribution.

Authors:  Xiankai Sun; Raffaella Rossin; Jeffrey L Turner; Matthew L Becker; Maisie J Joralemon; Michael J Welch; Karen L Wooley
Journal:  Biomacromolecules       Date:  2005 Sep-Oct       Impact factor: 6.988

3.  Albumin-based nanoparticles as magnetic resonance contrast agents: I. Concept, first syntheses and characterisation.

Authors:  M M Stollenwerk; I Pashkunova-Martic; C Kremser; H Talasz; G C Thurner; A A Abdelmoez; E A Wallnöfer; A Helbok; E Neuhauser; N Klammsteiner; L Klimaschewski; E von Guggenberg; E Fröhlich; B Keppler; W Jaschke; P Debbage
Journal:  Histochem Cell Biol       Date:  2010-02-20       Impact factor: 4.304

4.  A polysorbate-based non-ionic surfactant can modulate loading and release of beta-lactoglobulin entrapped in multiphase poly(DL-lactide-co-glycolide) microspheres.

Authors:  J Rojas; H Pinto-Alphandary; E Leo; S Pecquet; P Couvreur; A Gulik; E Fattal
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

5.  Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields.

Authors:  Michael Chorny; Ilia Fishbein; Benjamin B Yellen; Ivan S Alferiev; Marina Bakay; Srinivas Ganta; Richard Adamo; Mansoor Amiji; Gary Friedman; Robert J Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

6.  Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres?

Authors:  J M Péan; F Boury; M C Venier-Julienne; P Menei; J E Proust; J P Benoit
Journal:  Pharm Res       Date:  1999-08       Impact factor: 4.200

Review 7.  Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy.

Authors:  Zhibo Liu; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2016-03-07       Impact factor: 54.564

8.  Subtle changes to polymer structure and degradation mechanism enable highly effective nanoparticles for siRNA and DNA delivery to human brain cancer.

Authors:  Stephany Y Tzeng; Jordan J Green
Journal:  Adv Healthc Mater       Date:  2012-09-26       Impact factor: 9.933

9.  Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers.

Authors:  Stefanie Wohlfart; Alexander S Khalansky; Svetlana Gelperina; Olga Maksimenko; Christian Bernreuther; Markus Glatzel; Jörg Kreuter
Journal:  PLoS One       Date:  2011-05-06       Impact factor: 3.240

10.  Anthracycline Drugs on Modified Surface of Quercetin-Loaded Polymer Nanoparticles: A Dual Drug Delivery Model for Cancer Treatment.

Authors:  Chabita Saha; Agrima Kaushik; Asmita Das; Sandip Pal; Debashis Majumder
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.